Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « KwdFr.i » - entrée « Pneumopathie virale (traitement médicamenteux) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Pneumopathie virale (thérapie) < Pneumopathie virale (traitement médicamenteux) < Pneumopathie virale (transmission)  Facettes :

List of bibliographic references indexed by Pneumopathie virale (traitement médicamenteux)

Number of relevant bibliographic references: 629.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000013 (2021) Sujeet Jha [Inde] ; Nitish Batra [Inde] ; Samreen Siddiqui [Inde] ; Ashutosh Yadav [Inde] ; Archa Misra [Inde] ; Menka Loomba [Inde] ; Sumeet Sethi [Inde] ; Swati Waghdhare [Inde]HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers.
000132 (2021) Kanupriya Arora [Inde] ; Prasan Kumar Panda [Oman]Steroid harms if given early in COVID-19 viraemia.
000153 (2021) Kavita Manchanda [Inde] ; Jasbir Singh [Inde] ; Ranjeev Bhagat [Inde] ; Ilmjot Kaur Tiwana [Inde] ; Harmanjit Singh [Inde]Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective.
000296 (2021) Victoria Birlutiu ; Rares Mircea Birlutiu ; Liana Chicea [Roumanie]Off-label tocilizumab and adjuvant iron chelator effectiveness in a group of severe COVID-19 pneumonia patients: A single center experience.
000364 (2021) Pravash Budhathoki [Népal] ; Dhan Bahadur Shrestha [Népal] ; Sitaram Khadka [Népal] ; Era Rawal [Népal]Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis.
000398 (2021) Pankaj Bansal [États-Unis] ; Amandeep Goyal [États-Unis] ; Austin Cusick [États-Unis] ; Shubham Lahan [Inde] ; Harpal S. Dhaliwal [Inde] ; Poonam Bhyan [États-Unis] ; Pradnya Brijmohan Bhattad [États-Unis] ; Fawad Aslam [États-Unis] ; Sagar Ranka [États-Unis] ; Tarun Dalia [États-Unis] ; Lovely Chhabra [États-Unis] ; Devang Sanghavi [États-Unis] ; Bhavin Sonani [États-Unis] ; John M. Davis [États-Unis]Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.
000504 (2021) Nurullah Okumu [Turquie] ; Ne E Demirtürk [Turquie] ; R Za Aytaç Çetinkaya [Turquie] ; Rahmet Güner [Turquie] ; Smail Ya Ar Avc [Turquie] ; Semiha Orhan [Turquie] ; Petek Konya [Turquie] ; Bengü Aylan [Turquie] ; Ay Egül Karalezli [Turquie] ; Levent Yamanel [Turquie] ; Bircan Kayaaslan [Turquie] ; Gülden Y Lmaz [Turquie] ; Ümit Sava Ç [Turquie] ; Fatma Eser [Turquie] ; Gürhan Ta K N [Turquie]Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
000679 (2021) Davide Colombi [Italie] ; Flavio Cesare Bodini [Italie] ; Nicola Morelli [Italie] ; Mario Silva [Italie] ; Gianluca Milanese [Italie] ; Luigi Cavanna [Italie] ; Emanuele Michieletti [Italie]COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients.
000803 (2020) Lauren A. Schluenz ; Gerardo P. Ramos-Otero ; James J. Nawarskas [États-Unis]Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe?
000805 (2020) Naeem A. Alshoaibi [Arabie saoudite] ; Khadijah Maghrabi [Arabie saoudite] ; Haitham Alanazi [Arabie saoudite] ; Mousa Al Harbi [Arabie saoudite] ; Saleh Alghamdi [Arabie saoudite]Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19.
000806 (2020) Giuseppe Magro [Italie]SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
000807 (2020) Melanie Bilbul [États-Unis] ; Patricia Paparone [États-Unis] ; Anna M. Kim [États-Unis] ; Shruti Mutalik [États-Unis] ; Carrie L. Ernst [États-Unis]Psychopharmacology of COVID-19.
000818 (2020) Kalyan Kumar Gangopadhyay [Inde] ; Binayak Sinha [Inde] ; Samit Ghosal [Inde]"Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors - A survey".
000821 (2020) Cosima Rughini [Roumanie] ; Lorena Dima ; Sorina Vasile [Roumanie]Hydroxychloroquine and COVID-19: Lack of Efficacy and the Social Construction of Plausibility.
000834 (2020) Brandon S. Hamm [États-Unis] ; Lisa J. Rosenthal [États-Unis]Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae.
000838 (2020) Seema Rani [Inde] ; Sandeep Grover [Inde] ; Aseem Mehra [Inde] ; Swapnajeet Sahoo [Inde]Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.
000843 (2020) J Emilio Sánchez-Álvarez [Espagne] ; Miguel Pérez Fontán [Espagne] ; Carlos Jiménez Martín [Espagne] ; Miquel Blasco Pelícano [Espagne] ; Carlos Jesús Cabezas Reina [Espagne] ; Ángel M. Sevillano Prieto [Espagne] ; Edoardo Melilli [Espagne] ; Marta Crespo Barrios [Espagne] ; Manuel Macía Heras [Espagne] ; María Dolores Del Pino Y Pino [Espagne][SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN)].
000844 (2020) Anwar M. Hashem [Arabie saoudite] ; Badrah S. Alghamdi [Arabie saoudite] ; Abdullah A. Algaissi [Arabie saoudite] ; Fahad S. Alshehri [Arabie saoudite] ; Abdullah Bukhari [Arabie saoudite] ; Mohamed A. Alfaleh [Arabie saoudite] ; Ziad A. Memish [États-Unis]Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.
000846 (2020) Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Pierre-Edouard Fournier [France] ; Sophie Amrane [France] ; Marie Hocquart [France] ; Morgane Mailhe [France] ; Vera Esteves-Vieira [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Florian Correard [France] ; Audrey Giraud-Gatineau [France] ; Yanis Roussel [France] ; Cyril Berenger [France] ; Nadim Cassir [France] ; Piseth Seng [France] ; Christine Zandotti [France] ; Catherine Dhiver [France] ; Isabelle Ravaux [France] ; Christelle Tomei [France] ; Carole Eldin [France] ; Hervé Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Eric Chabrière [France] ; Anthony Levasseur [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Bernard La Scola [France] ; Philippe Parola [France] ; Didier Raoult [France]Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
000847 (2020) Ritesh Gupta [Inde] ; Anoop Misra [Inde]Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc).
000848 (2020) Anuj Sharma [États-Unis]Chloroquine paradox may cause more damage than help fight COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Pneumopathie virale (traitement médicamenteux)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Pneumopathie virale (traitement médicamenteux)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Pneumopathie virale (traitement médicamenteux)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021